Keywords: AA; arachidonic acid; Aβ; fibrillar β-amyloid; ACC; acetyl-CoA carboxylase; Akt; protein kinase B; APP; amyloid precursor protein; ASAH2; neutral ceramidase; BA; benzyl alcohol; BBB; blood-brain-barrier; BMI; body mass index; BPM; bis(monoacylglycero)
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: West syndrome; Dravet syndrome; mTOR; Epilepsy; Cognition; SUDEP; Arx; GABA; Sodium channels; Multiple-hit model; GABA; NMDA; Tetrodotoxin
Keywords: 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; BSA; bovine serum albumin; BT; beam test; CAT; catalase enzyme; CE; corticospinal pathway; CSB; circular small beam; CT; cylinder test; EA; enzyme activity; iNOS; inducible NO synthase; i.p.; intrape
Keywords: Classical eyeblink conditioning; Operant conditioning; Hippocampus; Prefrontal cortex; Mice; Rabbits; Long-term potentiation; Activity-dependent changes in synaptic strength; EMG; electromyographic; fEPSP; field excitatory post-synaptic potentials; HFS; h
Keywords: CNS; central nervous system; ENS; enteric nervous system; BBB; blood-brain-barrier; 5-HTP; 5-hydroxytryptophan; TPH; tryptophan hydroxylase; TDO; tryptophan-2,3-dioxygenase; IDO; indoleamine-2,3-dioxygenase; AAAD; aromatic amino acid decarboxylase; NMDA;
Keywords: 5-HT; 5-hydroxytryptamine, serotonin; CRF; corticotropin-releasing factor; HPA; hypothalamus-pituitary-adrenal; WHO; World Health Organization; DSM-5; Diagnostic and Statistical Manual of Mental Disorders 5; MOA; monoamine oxidase; VMAT; vesicular monoami
Keywords: AID/APOBEC; activation-induced cytidine deaminase/apolipoprotein B mRNA-editing enzyme complex; BDNF; brain-derived neurotrophic factor; 5caC; 5-carboxylcytosine; CBP; CREB binding protein; CREB; cAMP response binding protein; DNMT; DNA methyltransferases
Keywords: Melatonin; Neurogenesis; Hippocampus; Methamphetamine; NMDA;
Keywords: BA; Brodmann's area; PTSD; post traumatic stress disorder; GABA; gamma-amino butyric acid; 5-HT; 5-hydroxytryptamine; NMDA; N-methyl-d-aspartic acid; E/I balance; excitatory/inhibitory balance; PFC; prefrontal cortex; MD; mediodorsal; VLPFC; ventrolateral
Keywords: Dendritic spine; Synaptic plasticity; Neurodegenerative diseases; Psychiatric disorders; Glutamate receptor; Calcium signaling; ADHD; attention deficit hypersensitive disorders; FXS; Fragile X-syndrome; CNS; central nervous system; GABA; gamma amino butyr
Keywords: Copper; Synapse; Neurotransmission; Neurodegeneration; ATP7A; NMDA;
Keywords: Brain networks; Functional connectivity; Interneurons; Gamma-oscillations; NMDA; GABA; Lateral inhibition; Feedback inhibition; Feed-forward inhibition; Canonical neural computation; Motifs; Default mode network; fMRI; Schizophrenia;
Keywords: AMPA; alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid; AMPAR; alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor; CA1; cornu ammonis 1 hippocampal region; cDNA; complementary deoxyribonucleic acid; COX-2; cyclooxygenase 2; EAAT; ex
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ANOVA; one-way analysis of variance; APV; DL-2-amino-5-phosphonopentanoic acid; BSA; bovine serum albumin; CNQX; 6-cyano-7-nitroquinoxaline-2,3-dione; DHβE; dihydro-β-erythroidine; EPSCs; exci
Keywords: ADL; activities of daily living; COMT; catechol-O-methyltransferase; DOI; 2,5-dimethoxy-4-iodoamphetamine; GIRK; G-protein-gated inwardly rectifying potassium; GP; globus pallidus; GPCR; G protein-coupled receptor; GPe; external segment of GP; GPi; intern
Keywords: Fear extinction; Exposure therapy; Augmented relearning; Reconsolidation; Drug development; Cognitive enhancer; 5-HT; 5-hydroxytryptamine = serotonin; AC; adenylate cyclase; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMY; amygdala; BA;
Keywords: AD; Alzheimer disease; PD; Parkinson disease; MSA; multiple system atrophy; ALS; amyotrophic lateral sclerosis; NMDA; N-methyl-d-aspartate; GWASs; genome-wide association studies; SNPs; single-nucleotide polymorphisms; GCIs; glial cytoplasmic inclusions;
Keywords: Excitatory amino acid; AMPA; NMDA; PKA; PKC; CaMKII; Cdk5; Tyrosine kinase
Keywords: Mystixin; Brain slices; Epileptiform discharges; AMPA; NMDA; EPSP
Keywords: FGIDs; functional gastrointestinal disorders; IBS; irritable bowel syndrome; FD; functional dyspepsia; FH; functional heartburn; FC; functional constipation; ACC; anterior cingulate gyrus; PFC; prefrontal cortex; IC; insular cortex; VMR; Visceral Motor Re
Keywords: CeA; central nucleus of the amygdala; NMDA; N-methyl-d-aspartate; Amygdala; Descending pain control; NMDA receptor; Hemispheric lateralization; Submodality of pain;
Keywords: Catalepsy; Glutamate; Haloperidol; Inferior colliclus; NMDA; Striatum;
Keywords: CBS; cystathionine beta synthase; CPS1; carbamoyl-phosphate synthase 1; CUBN; cubilin; DPEP1; dipeptidase 1; FUT 2; fucosyltransferase 2; GABA; gamma-amino butyric acid; GTPB10; GTP-binding protein 10; HIS; International Headache Society; HNF1A; hepatocyt
Keywords: ethanol; LGICs; GABAA; NMDA; glycine; GLIC; crystal structures; PKC; trafficking; knockout; knockin mice; behavior; chronic alcohol consumption; gene expression
Keywords: NMDA; N-methyl-D-aspartate; HPA; Hypothalamic-pituitary-adrenal; CPA; Chlorpheniramine; CIM; Cimetidine; ICV; Intracerebroventricular; LTP; Long-term potentiation; Exercise; Spatial learning; Spatial memory; Histaminergic receptors;
Keywords: CPP; Conditioned place preference; RM Anova; Repeated Measures Analysis of Variance; CNS; Central Nervous System; NMDA; N-Methyl-D-Aspartate; pCREB; phosphorylated cAMP response element-binding protein; CNPq; National Counsel of Technological and Scientif
Keywords: ANOVA; Analysis of variance; BPI; Brief Pain Inventory; BLC; Big/Little Circle; DN4; Neuropathic pain in 4 questions; DX; Dextromethorphan; GNT; Graded Naming Test; HAD; Hospital Anxiety and Depression scales; IST; Information Sampling Task; LSEQ; Leeds S
Keywords: MTs; microtubules; OE; olfactory neuroepithelium; Nz; nocodazole; NMDA; N-methyl-d-aspartate; MAPs; microtubule associated proteins; DISC1; disrupted-in-schizophrenia-1; DLPFC; dorsolateral prefrontal cortex; NUDEL; nuclear distribution protein nude-like
Keywords: FASD; fetal alcohol spectrum disorder; FAS; fetal alcohol syndrome; pFAS; partial fetal alcohol syndrome; ARND; alcohol-related neurodevelopmental disorder; GD-7; gestational day 7; GABA; γ-amino-butyric acid; PET; position emission tomography; PV; parva
Keywords: NMDA; autoimmune; encephalitis; immunotherapy
Keywords: AD; Alzheimer's disease; NMDA; N-methyl-d-aspartate; CNS; central nervous system; PNS; peripheral nervous system; MT; microtubules; MBP; myelin basic protein; Tau; Pain; Peripheral nerve; Myelination; C-fibers;
Keywords: UA; ursolic acid; TST; tail suspension test; PCPA; Ï-chlorophenylalanine; NMDA; N-methyl-d-aspartate; AMPT; α-methyl-Ï-tyrosine; Antidepressant; Monoaminergic system; Ursolic acid; Tail suspension test;
Keywords: Bipolar disorder; Alcohol; Glutamate; NMDA; Mismatch negativity; Temporal;
Keywords: ADs; afterdischarges; ANOVA; analysis of variance; EEG; electroencephalography; GD; gestational day; MA; methamphetamine; M/D; metestrus/diestrus; NMDA; N-Methyl-D-Aspartate; P/E; proestrus/estrus; PD; postnatal day; SADs; spontaneous ADs; S.E.M.; standar
Keywords: aCSF; artificial cerebrospinal fluid; fEPSP; field excitatory post synaptic potential; GR; glucocorticoid receptor; HFS; high frequency stimulation; LTD; long-term depression; LTP; long-term potentiation; MWM; Morris water maze; NMDA; N-methyl-d-aspartate
Keywords: ACTH; adrenocorticotropic hormone; ANOVA; analysis of variance; BDNF; brain-derived neurotrophic factor; Co; Control group; CORT; corticosterone; DG; dentate gyrus; EPSP; excitatory postsynaptic potential; fEPSP; field excitatory postsynaptic potential; G
Keywords: CRF; corticotropin releasing factor; GABA; gamma-aminobutyric acid; GAD; glutamic acid decarboxylase (65/67); GS; glutamine synthetase; HIV; human immunodeficiency virus; NADPH; nicotinamide adenine dinucleotide phosphate; NMDA; N-methyl-d-aspartate; NO;
Keywords: ACC; anterior cingulate cortex; AD; Alzheimer's disease; AI; anterior insula; BG; basal ganglia; dACC; dorsal anterior cingulate cortex; CC; cingulate cortex; CA; cornu ammonis; CA3; cornu ammonis region 3; CA4; cornu ammonis region 4; CRP; C-reactive pro
Keywords: Mouse embryonic stem cells; NMDA; Ketamine; Neurogenesis; Mesoendoderm; Differentiation
Keywords: Midazolam; Morphine tolerance; Hyperactivity; Young rats; Burn injury; NMDA; NR1; PKC
Keywords: 5-HT; serotonin; CCI; chronic constriction injury; COX-2; cyclooxygenase-2; DLPT; dorsolateral pontine tegmentum; DOI; (±)-2.5-dimethoxy-4-iodoamphetamine; GSH; glutathione; HPLC; high performance liquid chromatography; l-NMMA; NG-monomethyl-l-arginine;
Keywords: Th1; type 1 T helper cells; Th2; type 2 T helper cells; CNS; central nervous system; BBB; blood-brain barrier; IL-2; interleukin-2; IL-12; interleukin-12; IL-10; interleukin-10; IL-4; interleukin-4; IL-6; interleukin-6; TNF-α; tumor necrosis factor a
Keywords: Mitochondria; Mitochondrial diseases; Neurodegenerative disorders; Pharmacological neuroprotection; Mitochondrie; Maladies mitochondriales; Maladies neurodégénératives; Neuroprotection pharmacologique; AD; Alzheimer's disease; AICAR; 5-aminoimidazole-4
Keywords: AUD; alcohol use disorder; BBB; blood brain barrier; BDNF; brain-derived neurotrophic factor; BEC; blood ethanol concentration; cAMP; cyclic adenosine monophosphate; CNS; central nervous system; CREB; cAMP-responsive element binding; FAAH; fatty acid amid
Keywords: AC; adenylate cyclase; AD; Alzheimer's disease; AMPA; alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; AOAA; aminooxyacetate; cAMP; cyclic adenosine monophosphate; CBS; cystathionine β-synthase; CNS; central nervous system; CSE; cystathionine
Keywords: ELISA; enzyme-linked immunosorbent assay; PURE; protein synthesis using recombinant elements; NMDA; N-methyl-d-aspartate; LOD; level of detection; QD; quantum dot; CV; coefficient of variation; Autoimmune disease; Autoantibody; Protein microarray;
Keywords: Amphetamine; Endocannabinoids; Glutamate; Monoamines; Endogenous opioids; Pharmacology; 5-HT; serotonin; ACh; acetylcholine; ADHD; attention-deficit/hyperactivity disorder; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BDNF; brain-derived n
Keywords: LPS; lipopolysaccharide; Poly I:C; polyinosinic-polycytidylic acid; IL; interleukin; TNF-α; tumor necrosis factor-alpha; COR; corticosterone; HPA; hypothalamic-pituitary-adrenal; EPM; elevated plus maze; FST; forced swimming test; OF; open field; LDB;
Keywords: CP; critical period; FS; fast-spiking; LTD; long-term depression; LTP; long-term potentiation; MD; monocular deprivation; MHC1; major histocompatibility complex class 1; NMDA; N-methyl-d-aspartate; ODP; ocular dominance plasticity; PirB; paired-immunoglob
Keywords: Prelimbic cortex; Subthalamic nucleus; Reversal learning; NMDA; Muscimol; Executive functioning